Identifying the right finance for growing firms is a cornerstone of the government’s Industrial Strategy, and the Review will help these businesses navigate their future growth as we prepare to leave the European Union.
What is the Patient Capital Review?
The review set out to strengthen the UK further as a place for growing innovative firms to obtain the long-term ‘patient’ finance that they need to scale up, building on current best practices.
The review considered all aspects of the financial system affecting the provision of long-term finance to growing innovative firms. The review was led by HM Treasury and reported to the Chancellor. It will worked closely with the Department for Business, Energy and Industrial Strategy and the British Business Bank.
Why does this matter?
It’s important that business works with the government to shape the funding provision for growing and innovative firms, which must be robust and adequately support entrepreneurial businesses on their scale up journey.
The review began work in January 2017 with the CBI responding to the consultation Financing innovative firms as part of the Review in September 2017. The CBI continues to work with HM Treasury, BEIS and the British Business Bank to ensure members can access the finance they need to grow.